Antonio Frassoldati


Affiliation: St. Anna Hospital
Country: Italy


  1. Lupini L, Moretti A, Bassi C, Schirone A, Pedriali M, Querzoli P, et al. High-sensitivity assay for monitoring ESR1 mutations in circulating cell-free DNA of breast cancer patients receiving endocrine therapy. Sci Rep. 2018;8:4371 pubmed publisher
    ..Because of its high sensitivity, the approach may potentially be applicable to patients with non-metastatic disease. ..
  2. Gori S, Puglisi F, Cinquini M, Pappagallo G, Frassoldati A, Biganzoli L, et al. Adjuvant endocrine therapy in premenopausal patients with hormone receptor-positive early breast cancer: Evidence evaluation and GRADE recommendations by the Italian Association of Medical Oncology (AIOM). Eur J Cancer. 2018;99:9-19 pubmed publisher
  3. Da Ros L, Moretti A, Querzoli P, Pedriali M, Lupini L, Bassi C, et al. HER2-Positive Lobular Versus Ductal Carcinoma of the Breast: Pattern of First Recurrence and Molecular Insights. Clin Breast Cancer. 2018;18:e1133-e1139 pubmed publisher
    ..Despite lower proliferation activity and estrogen receptor expression in ILC breast cancer, trastuzumab is clearly an effective therapy for this histologic subtype. ..